| Literature DB >> 34940620 |
Vincent Hamani1, Pascaline Ory1, Pierre-Edouard Bodet1, Laurence Murillo1, Marianne Graber1.
Abstract
Ports are a good example of how coastal environments, gathering a set of diverse ecosystems, are subjected to pollution factors coming from human activities both on land and at sea. Among them, trace element as copper represents a major factor. Abundant in port ecosystem, copper is transported by runoff water and results from diverse port features (corrosion of structures, fuel, anti-fouling products, etc.). The variegated scallop Mimachlamys varia is common in the Atlantic port areas and is likely to be directly influenced by copper pollution, due to its sessile and filtering lifestyle. Thus, the aim of the present study is to investigate the disruption of the variegated scallop metabolism, under a short exposure (48 h) to a copper concentration frequently encountered in the waters of the largest marina in Europe (82 μg/L). For this, we chose a non-targeted metabolomic approach using ultra-high performance liquid chromatography coupled to high resolution mass spectrometry (UHPLC-HRMS), offering a high level of sensitivity and allowing the study without a priori of the entire metabolome. We described 28 metabolites clearly modulated by copper. They reflected the action of copper on several biological functions such as osmoregulation, oxidative stress, reproduction and energy metabolism.Entities:
Keywords: UHPLC/QToF mass spectrometry; copper; metabolomics; scallop
Year: 2021 PMID: 34940620 PMCID: PMC8703567 DOI: 10.3390/metabo11120862
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Figure 1Score plots of PCA and PLS-DA for positive mode (LC-Positive), negative mode (LC-Negative) of liquid chromatography. The dotted ellipse represented the confidence limit (95%) of Hotelling’s T2 statistic. The control samples and the Cu-exposed samples are visually grouped in green and red ellipses, respectively.
Metabolites varying after 48 h copper exposure (82 μg/L). The score represents the Shymanski classification. The power of the modulation (Copper effect) is measured as the difference between the relative spectral intensity means.
| Metabolite | Mode | Retention (min) | Formula | Monoisotopic | Adduct | Observed Mass ( | Theoretical Mass ( | Mass Error (ppm) | Score | Copper Effect | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Carbohydrate | Trisaccharides | Pos | 1.45 | C18H32O16 | 504.1690 | [M + H]+ | 505.1777 | 505.1763 | 2.8 | 2a | |
| Tetrasaccharides | Pos/Neg | 1.46 /2.52 | C24H42O21 | 666.2219 | [M + H]+ | 689.2123/665.2133 | 667.2291 | 1.5/2 | 2a | ||
| Pentasaccharides | Pos | 4.64 | C30H52O26 | 828.2747 | [M + H + K]2+ | 434.1180 | 434.1226 | 10.5 | 2a | ||
| Hexasaccharides | Pos | 5.72 | C36H62O31 | 990.3275 | [M + H + K]2+ | 515.1465 | 515.1490 | 4.9 | 2a | ||
| Peptide & AAC | Peptide Val-Asp | Pos | 3.28 | C9H16N2O5 | 232.1059 | [M + H]+ | 233.1136 | 233.1132 | 1.6 | 2a | |
| Peptide HydroxyPro-Tyr | Pos | 4.16 | C14H18N2O5 | 294.1216 | [M + H]+ | 333.0862 | 333.0847 | 4.5 | 2a | ||
| N5-Acetyl-N2-gamma- | Pos | 4.64 | C12H21N3O6 | 303.1430 | [M + H]+ | 304.1507 | 304.1503 | 1.3 | 2a | ||
| S-(Formylmethyl)glutathione | Pos | 6.39 | C12H19N3O7S | 349.0944 | [M+Na]+ | 372.0856 | 372.0836 | 5.2 | 2b | ||
| Peptide Pro-Arg | Pos | 8.06 | C11H21N5O3 | 271.1644 | [M + H]+ | 310.1288 | 310.1276 | 4.0 | 2a | ||
| Glycylalanylprolylmethionylphenylalanylvalinamide | Pos/Neg | 8.27 | C29H45N7O6S | 619.3152 | [M+2H]2+/ [M − H]− | 310.6649/618.3034 | 310.6649/618.3079 | 0/7.3 | 2b | ||
| Aspartic acid | Neg | 1.11 | C4H7NO4 | 133.0375 | [M − H]− | 132.0295 | 132.0302 | 5.5 | 1 | ||
| Leucine | Neg | 3.3 | C6H13NO2 | 131.0946 | [2M − 2H + Na]− | 283.1629 | 283.1634 | 1.7 | 1 | ||
| N-Acetyl- | Neg | 5.74 | C7H11NO4 | 173.0688 | [M − H]− | 172.0608 | 172.0615 | 4.3 | 2a | ||
| Oxidized glutathione | Neg | 6.12 | C20H32N6O12S2 | 612.152 | [M − H]− | 611.1436 | 611.1447 | 1.8 | 2a | ||
| Lipid | Diglyceride (9M5/9D3/0:0) or (11M3/9D3/0:0) or (9D3/11M3/0:0) or (9D3/9M5/0:0) | Pos | 6.49 | C40H66O7 | 658.4809 | [M + H + K]2+ | 349.2269 | 349.2256 | 3.8 | 3 | |
| Phosphatidic acid | Pos | 7.11 | C41H69O8P | 720.4730 | [M + H + K]2+ | 380.2225 | 380.2217 | 2.1 | 3 | ||
| Cytidine diphosphate diacylglycerol or CDP-diacylglycerol (CDP-DG) | Pos | 7.48 | C45H83N3O15P2 | 967.5299 | [M+H+Na]2+ | 495.7663 | 495.7632 | 6.3 | 3 | ||
| Adipoyl-CoA | Neg | 6.81 | C27H44N7O19P3S | 895.1626 | [M − 2H]2− | 446.5629 | 446.5740 | 24.8 | 2a | ||
| S-(PGA1) or S-(9-deoxy-D12-PGD2) or S-(11-OH-9-deoxy-D9,12-PGD2) or S-(9-deoxy-delta9,12-PGD2) or S-(PGJ2) or S-(PGA2)-glutathione | Neg | 8.58 | C30H47N3O10S | 641.2982 | [M − H]− | 640.2889 | 640.2909 | 3.1 | 3 | ||
| Leukotriene C4 or 11-trans-Leukotriene C4 | Neg | 10.3 | C30H47N3O9S | 625.3033 | [M − H]− | 624.2950 | 624.2960 | 1.6 | 3 | ||
| Prostaglandin D1, E1, F2 or H1 or as 8-isoprostaglandin F2 or E1 | Neg | 12.88 | C20H34O5 | 354.2406 | [M − H]− | 353.2325 | 353.2333 | 2.3 | 3 | ||
| Lysophosphatidyléthanolamines (lysoPE) (P-16:0/0:0) and (0:0/18:2(9Z,12Z)) | Neg | 17.31/ 17.36 | C21H44NO(6/7)P | 437.2906/477.2855 | [M − H]− | 436.2816/476.2769 | 436.2833/476.2782 | 4/2.8 | 3 | ||
| N-Palmitoyltaurine | Neg | 18.43 | C18H37NO4S | 363.2443 | [M − H]− | 362.2360 | 362.2371 | 3.1 | 2a | ||
| 3-Hydroxyoctadecenoylcarnitine | Neg | 18.7 | C25H47NO5 | 441.3454 | [M + K − 2H]− | 478.295 | 478.294 | 2.1 | 3 | ||
| Phosphatidylserine 20:5(5Z,8Z,11Z,14Z,17Z) or 18:3(9Z,12Z,15Z) or 18:4(6Z,9Z,12Z,15Z) or 20:4(8Z,11Z,14Z,17Z) | Neg | 19.51 | C44H70NO10P | 824.4495/803.4737 | [M + Na − 2H]−/[M − H]− | 824.4495/802.4676 | 824.4484/802.4665 | 1.3/1.4 | 3 | ||
| Lysophosphatidylcholine (LysoPC) (18:2(9Z,12Z)/0:0) or (0:0/18:2(9Z,12Z)) | Neg | 20.54 | C26H50NO7P | 519.3325 | [M − H]− | 518.3237 | 518.3252 | 2.9 | 3 | ||
| Ceramide phosphoethanolamines (PE-Cer) (d15:2(4E,6E)/20:0(2OH)) | Neg | 20.63 | C37H73N2O7P | 688.5155 | [M − H]−/[M + K − 2H]− | 687.5066 | 687.5083 | 2.5 | 3 | ||
|
| 2-Hydroxyadenine or Guanine | Pos | 4.52 | C5H5N5O | 151.0494 | [M + H]+ | 152.057 | 152.0567 | 2.0 | 2b/3 |
Figure 2Metabolites found in the gills of scallop showing a significant difference between control and copper-exposed samples (48 h at 82 μg/L) classified by family and box plots of their relative spectral intensity.
Figure 3Comparison of chromatograms and mass spectrometry spectra between Standards (left) and QC samples (right) for identification of leucine and aspartic acid. Mass spectrometry spectra for the leucine standard (A), for the leucine in QC sample (B), for the aspartic acid standard (G) and for the aspartic acid in QC sample (H). Extracted Ion Chromatograms (EIC) for the leucine standard (C), for the leucine in QC sample (D), for the aspartic acid standard (I) and for the aspartic acid in QC sample (J). Total ion current chromatograms for the leucine standard (E), for the leucine in QC sample (F), for the aspartic acid standard (K) and for the aspartic acid in QC sample (L). * Peaks of interest.